Results
1 -
10 of
14David E. Green, Meryn L. Bowen, Lauren E. Scott, Tim Storr, Michael Merkel, Karin Böhmerle, Katherine H. Thompson, Brian O. Patrick, Harvey J. Schugar and Chris Orvig.
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease, Dalton Trans., 2010, 39, 1604. Kay Severin.
Boronic acids as building blocks for molecular nanostructures and polymeric materials, Dalton Trans., 2009, 5254. Lauren E. Scott, Maria Telpoukhovskaia, Cristina Rodríguez-Rodríguez, Michael Merkel, Meryn L. Bowen, Brent D. G. Page, David E. Green, Tim Storr, Fancy Thomas, David D. Allen, Paul R. Lockman, Brian O. Patrick, Michael J. Adam and Chris Orvig.
N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy, Chem. Sci., 2011, 2, 642. Molecular recognition of synthetic siderophore analogues: A study with receptor-deficient and fhu(A-B) deletion mutants of Escherichia coli, Biometals L-Mimosine (??-(3-Hydroxy-4-Pyridone-1-yl)-L-Alanine), Plant Secondary Metabolites l-Mimosine synthase, Class 2 ?? Transferases VI L-Mimosine synthase, Enzyme Handbook 17 Mimosinase, Enzyme Handbook 16 Allelopathy in Brazil, Allelopathy Transformation of 3-hydroxypyridine by Pseuodomonas fluorescens and Rhodococcus opacus strains, Chemistry of Heterocyclic Compounds